ROBERT C. GREEN, MD, MPH
A recognized leader in the field of genomics and health and a member of Coriell's Informed Cohort Oversight Board, Dr. Robert Green brings his expertise in population genetics and genomic health outcomes to the cutting-edge Coriell Personalized Medicine Collaborative research study. Associate Professor of Medicine in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School in Boston, Dr. Green is an accomplished leader in his field who has published more than 300 scientific articles and has made tremendous contributions as the director of The REVEAL Study and The MedSeq Project and as the co-director of The BabySeq Project and The PGen Study, examining the integration of whole genome sequencing into clinical medicine.
GREG DOWNING, DO, PhD
The Executive Director for Innovation in the Immediate Office of the Secretary at the U.S. Department of Health and Human Services, Dr. Downing shapes agency policies to promote innovation and entrepreneurship in research and healthcare. For five years, he served as the director for the agency's Personalized Healthcare Initiative, a cross-cutting strategic priority to accelerate the entry of genomic science into mainstream medical practice. He has championed many issues important to national health policy and Coriell's research agenda. Dr. Downing has also held leadership positions in science policy and advanced technology programs at the National Institutes of Health since 1993. He earned his MD from Michigan State University, completed a pediatric residency at UMDNJ, and neonatology fellowship at Children's Mercy Hospital in Kansas City, MO. He holds a PhD in pharmacology from the University of Kansas. Dr. Downing remains active as a pediatrician in the Washington, D.C. area where he enjoys creating healthy futures for children and their families.
CHARLES N. LORD
Mr. Charles N. Lord has been an exceptional advocate on behalf of Coriell for more than 20 years. Mr. Lord has raised more than one million dollars for the Institute's personalized medicine program, in addition to introducing the Coriell mission to several influential leaders within the region. An award-winning journalist at both the national and local levels and a successful businessman, Mr. Lord is among the most dedicated members of the Coriell Board of Trustees. His passion and interest in the science at Coriell has made him a life-long asset to Coriell.
HOWARD MCLEOD, PHARMD
Coriell Scientific Award, 2012
An internationally-recognized expert in the field of pharmacogenomics, Dr. McLeod's research has helped identify genetic variations that predispose patients to risk of severe side effects or inadequate benefit from drugs. His research also modified FDA dosing guidelines for warfarin, a blood thinner prescribed to more than 2 million people in the United States. Dr. McLeod is the Fred Eshelman Distinguished Professor and director of the UNC Institute for Pharmacogenomics and Individualized Therapy, and serves on Coriell's Pharmacogenomics Advisory Board.
LINDA M. ROHRER
Coriell Humanitarian Award, 2012
Highly regarded for her dedication to making Camden County a great place to work, live, and raise a family, Ms. Rohrer has supported numerous initiatives, including the Coriell Personalized Medicine Collaborative, through her work as trustee for the William G. Rohrer Charitable Foundation. Specifically, Ms. Rohrer and the Foundation have been instrumental in helping Coriell establish the integrated technology architecture essential to storing, mining, and analyzing the extraordinary volumes of data generated by the CPMC research study. Ms. Rohrer is President of Rohrer & Sayers Real Estate.
PETER E. DRISCOLL, ESQ.
Coriell Ambassador Award, 2012
As Coriell moved into the emerging field of personalized medicine, Mr. Driscoll drew upon his relationships in the region to successfully attract financial support for the establishment of Coriell's multi-million dollar Genome Center and award-winning laboratory renovations. Mr. Driscoll's stewardship of these and other developments has proven central to the success of the Coriell Personalized Medicine Collaborative research study and Coriell's innovative approach to research. A Coriell Board Trustee, Mr. Driscoll served as Chariman of Coriell Board from 2004 to 2011.
LAWRENCE J. LESKO, PhD, FCP
Coriell Scientific Award, 2010
Lawrence J. Lesko, PhD, FCP, is the Director of the Office of Clinical Pharmacology in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration and is Board Certified in Clinical Pharmacology by the American Board of Clinical Pharmacology. He is Chair of the FDA Pharmacogenomics Working Group and the Clinical Pharmacology Section of the Medical Policy Coordinating Committee in CDER and served as the President of the American College of Clinical Pharmacology (ACCP) from 2004-2006. Dr. Lesko is also an elected American Association of Pharmaceutical Scientist Fellow, a Fellow in the ACCP and a Fellow in the Japanese Society for the Study of Xenobiotics.
FRANK & DOROTHY GIORDANO
Coriell Ambassador Award, 2010
Frank Giordano is President of Atlantic Trailer Leasing Corp., a transportation and storage equipment company that has been in the Giordano family since 1949, and previously served as the 64th President of the Union League of Philadelphia. Mr. Giordano joined the Coriell Board of Trustees in 1989 and became a Life Trustee and Distinguished Fellow in 1994. He has chaired the Executive Committee and was instrumental in the commercial development of the cryogenic preservation and collection of core blood.
Dorothy Giordano, a civic and community volunteer, is president of the Friends of Coriell Committee and served for many years on the Women's Board of Cooper University Hospital. Mrs. Giordano is a spousal member of the Union League of Philadelphia and has chaired the Ladies Committee, the Public affairs Committee and the Union League Crystal Awards.